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Insomnia is common in people experiencing psychosis. It has been identiﬁed as a contributory cause of
paranoia, but any causal relationship with hallucinations has yet to be established. We tested the hy-
potheses that insomnia i) has a cross-sectional association with hallucinations ii) predicts new inceptions
of hallucinations and iii) that these associations remain after controlling for depression, anxiety, and
paranoia. Data from the second (2000, N¼8580) and third (2007, N¼7403) British Psychiatric Morbidity
Surveys were used to assess cross-sectional associations between insomnia and hallucinations. The 2000
dataset included an 18 month follow up of a subsample (N¼2406) used to test whether insomnia
predicted new inceptions of hallucinations. Insomnia was associated with hallucinations in both cross-
sectional datasets. Mild sleep problems were associated with 2–3 times greater odds of reporting hal-
lucinations, whilst chronic insomnia was associated with four times greater odds. Insomnia was also
associated with increased odds of hallucinations occurring de novo over the next 18 months. These as-
sociations remained signiﬁcant, although with smaller odds ratios, after controlling for depression, an-
xiety and paranoia. This is the ﬁrst longitudinal evidence that insomnia is associated with the devel-
opment of hallucinatory experiences. Effective treatment of insomnia may lessen the occurrence of
hallucinations.
& 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Insomnia is a common psychological disorder: approximately
one third of the adult general population report disrupted sleep
(Ohayon, 2002; Morphy et al., 2007), and around 6–10% will meet
diagnostic criteria for insomnia disorder (Ohayon, 2002; Walsh,
2004). The importance of sleep in psychotic illness is beginning to
be recognised (for a review of the area see: Reeve et al., 2015). For
example, sleep disturbance is a risk factor for ﬁrst episode psy-
chosis (Ruhrmann et al., 2010) and subsequent relapse (Birchwood
et al., 1989). There is also evidence of sleep and circadian rhythm
disruption in patients with schizophrenia (Wulff et al., 2012;
Afonso et al., 2014). Of individual psychotic experiences, only the
relationship between paranoia and insomnia has receivedIreland Ltd. This is an open acces
ychiatry, Warneford Hospital,
. Sheaves).sustained attention (Reeve et al., 2015). Insomnia is very common
in patients with persecutory delusions (Freeman et al., 2009), and
predicts new inceptions and the persistence of persecutory idea-
tion (Freeman et al., 2012). The association between insomnia and
paranoia is partially mediated by affective symptoms (Freeman
et al., 2010). This has led to sleep disruption being targeted in
treatment (Freeman et al., 2015a; Waite et al., 2016; Myers et al.,
2011). Indeed sleep disruption (and the impact on daytime psy-
chotic symptoms) is highlighted as a problem that patients
themselves would value help with, and treating sleep disruption in
this group has proved a popular approach (Waite et al., 2015a).
Recent studies provide the ﬁrst evidence that sleep disruption and
hallucinations are cross-sectionally associated (Koyanagi and
Stickley, 2015; Taylor et al., 2015; Sheaves et al., 2016) This study
will add to this emerging literature by assessing the cross sectional
and longitudinal association between insomnia and hallucinations.
There are plausible mechanisms that may link the occurrence
of insomnia with hallucinations. A recent twin study of 4800
adolescents demonstrated that 60–71% of the covariance betweens article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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genetic inﬂuences (Taylor et al., 2015). Non-shared environment
accounted for the remaining 29–40% of covariance (Taylor et al.,
2015). These links decreased, though remained signiﬁcant after
controlling for negative affect (Taylor et al., 2015). A speciﬁc as-
sociation between insomnia and hallucinations was also in-
vestigated. A phenotypic correlation of .37 was reported between
insomnia and hallucinations. The bivariate heritability (proportion
of the association between these two phenotypes attributable to
additive genetic effects) was .63, whilst the bivariate non-shared
environment was .37 (Taylor et al., 2015).
Enhanced dopaminergic activity mediated via dopamine D2
receptors may underlie both positive symptoms of psychosis and
increased wakefulness (Monti and Monti, 2005). Moreover, redu-
cing sleep duration (i.e. sleep deprivation) can lead to anomalies of
experience with close similarities to auditory hallucinations (Luby
et al., 1960; West et al., 1962). It is highly likely that affective
symptoms will mediate the association between insomnia and
hallucinations, as shown for insomnia and paranoia (Freeman
et al., 2010). Insomnia substantially increases the risk of affective
disturbance (Baglioni et al., 2011) and insomnia treatment trials
provide preliminary evidence for a causal relationship with af-
fective symptoms (Manber et al., 2008; Espie et al., 2012). In turn,
affective disturbance is extremely common in people experiencing
clinical hallucinations and has long been recognised in cognitive
models of psychosis (Morrison, 1998; Garety et al., 2001; Beck and
Rector, 2003). In Beck and Rector's (2003) cognitive model, hal-
lucinations manifest in part due to affective disturbance decreas-
ing the threshold for hypervalent (or ‘hot’) cognitions to be ex-
perienced as identical to externally generated sounds (auditory
hallucinations). In support of their association, there is evidence
that affective symptoms trigger the onset (Slade, 1973) severity
(Norman and Malla, 1991; Smith et al., 2006) and persistence of
hallucinations (Escher et al., 2002; De Loore et al., 2011).
Psychotic experiences are not conﬁned to patient groups, but
also commonly occur in the general population (Johns et al., 2004;
van Os et al., 2009). For example, 28.4% of a US community sample
endorsed one or more Psychosis Screening Questionnaire (PSQ)
items (Bebbington and Nayani, 1995), currently, whilst only 0.2–
0.7% of the sample met diagnostic criteria when assessed by a
clinician (Kendler et al., 1996). The persistence of these psychotic
experiences over time increases the risk of transition to clinical
psychosis (Dominguez et al., 2009). Nationally representative
surveys can provide large-scale epidemiological tests of the asso-
ciations of psychotic experiences with potential causal factors
(Freeman et al., 2012; Marwaha et al., 2014). The current study
seeks to establish from nationally representative UK survey data
whether insomnia and hallucinatory experiences are associated.
The following hypotheses were tested. i) Insomnia will be asso-
ciated with the occurrence of hallucinatory experiences ii) sleep
difﬁculties will predict the emergence of new hallucinatory ex-
periences and iii) that these associations remain signiﬁcant (albeit
smaller) after controlling for affective symptoms (depression and
anxiety) and paranoia.2. Method
2.1. Setting and design
The second and third British adult psychiatric morbidity surveys aimed to as-
sess the prevalence of mental health problems in adults living in private house-
holds. People aged 16–74 living in England, Wales and Scotland were included in
the 2000 survey (N¼8580, response rate¼70%) and adults aged 16þ living in
England were included in the 2007 survey (N¼7403, response rate¼57%). In both
surveys the households were drawn from the small user Postal Address File. This
includes all delivery points receiving less than 50 pieces of mail per day. Postalsectors were selected with a probability proportional to size. One person was se-
lected per household. In 2000 the Kish grid method systematically selected one
individual and in 2007, the individual was selected randomly. Two phases of in-
terviews were completed for each single time point; phase one included structured
assessments and screening measures, phase two was completed by clinically
trained interviewers. Cases of psychotic disorder were identiﬁed in both surveys.
Participants were screened for possible psychosis during phase 1, a process that
included the PSQ (Bebbington and Nayani, 1995). They were invited for a phase
2 assessment of psychosis if they met one or more of the following criteria:
 Currently on antipsychotic medication.
 Hospital admission for mental health problems in the past 3 months.
 Positive response to question 5a on the PSQ (relating to auditory hallucinations).
 A self-reported diagnosis of psychotic disorder or of symptoms suggestive of it.
Participants not meeting any of these criteria were assumed not to have psy-
chosis. For people interviewed in phase 2, the diagnosis of psychosis was based on
the Schedule for Clinical Assessment in Neuropsychiatry (SCAN) (WHO, 1999). The
category of “probable psychosis” included those diagnosed at SCAN interview, to-
gether with people who were not interviewed with SCAN, but met two of the above
screening criteria.
In the 2000 survey, a sub-sample (N¼2406) was interviewed 18 months fol-
lowing their initial interview to provide longitudinal data. Respondents to the 2000
survey were split into three groups: those with an identiﬁed mental disorder, those
without a diagnosis but endorsing some symptoms of common mental disorders,
and those reporting no symptoms. All those in sample groups one and two were
included in the follow up, and 1 in 5 of the third group were interviewed, in order
to avoid over-representation of this latter group. Further details regarding survey
design can be found in previous methodological reports (Singleton et al., 2000;
McManus et al., 2009).
The presence of hallucinations over the past 12 months was assessed using two
items from the PSQ (Bebbington and Nayani, 1995). H1: Have there been times
when you heard/saw things that other people couldn't? (PSQ5, yes/no) and H2: Did
you at any time hear voices saying quite a few words or sentences when there was
no one around that might account for it? (PSQ5a, yes/no). The full PSQ had a
sensitivity of 96.9% and a speciﬁcity of 95.3% when compared with a clinical in-
terview (Schedules for Clinical Assessment in Neuropsychiatry; Wing et al., 1990),.
Three levels of insomnia were calculated from items from the Clinical Interview
Schedule Revised (CIS-R; Lewis et al., 1992), as in previous studies (Freeman et al.,
2010):
I1: Endorsement of sleep difﬁculties over the past month (D1).
I2: Insomnia of moderate severity: Sleep difﬁculties (I1) for at least three nights
per week (D3) and taking at least one hour to attain sleep (either initially attaining
sleep, or returning to sleep; D5).
I3: Chronic insomnia: Insomnia of moderate severity (I2), which has lasted at
least six months (D10) and reports of tiredness (B1).
Chronic insomnia is broadly representative of diagnostic criteria for Insomnia
Disorder: a difﬁculty initiating or returning to sleep, which occurs at least three
nights per week, for at least three months, with reports of daytime impairment
(American Psychiatric Association, 2013).
A dimensional insomnia variable was calculated for longitudinal analysis in
order to increase power for analysing this smaller sample. This summed CIS-R
items assessing difﬁculties getting to or staying asleep (D1), number of nights with
a sleep problem (D3), how much time spent getting to sleep (D5), number of nights
spent longer than three hours trying to sleep (D6), early morning waking (D7),
length of time experiencing sleep problems (D10) and reports of tiredness (B1). The
score could range from 0 to 14.
Adjustments were made for current depression and anxiety using CIS-R
symptom count scores (DVG11 and DVJ12). These measured frequency, duration,
severity and time since onset of both anxiety and depression in the week prior to
interview. Possible scores lay between zero and four. Adjustments for paranoia
used an item from the PSQ: Have there been times when you felt that people were
deliberately acting to harm you or your interests? (PSQ3a).
2.2. Analysis
The data were analysed using the Statistical Package for the Social Sciences
(SPSS, version 19). All datasets were weighted to ensure they were representative
of the national population by accounting for sampling rates, probability of selecting
respondents, age, sex and region. Further weights were applied to the longitudinal
dataset to account for the differential selection for follow-up interview. Binary
logistic regression was used to assess the association between insomnia and hal-
lucinations using three stages of analysis. Stage one reports unadjusted odds ratios,
stage two adjusted for depression and anxiety, and stage three adjusted for de-
pression, anxiety and paranoia. These adjustments were made in the light of al-
ready established associations linking insomnia with affective symptoms (Johnson
et al., 2006) and paranoia (Freeman et al., 2010), both of which commonly co-occur
with hallucinations. 95% conﬁdence intervals (C.I.) are reported for the odds ratios.
Table 2
The frequency and weighted prevalence of sleep disruption and hallucinations in
those with probable psychosis.
2000 2007
Frequency Weighted pre-
valence (%)
Frequency Weighted pre-
valence (%)
Sleep
difﬁculties
40 66.5 25 67.5
Insomnia 22 36.3 13 33.8
Chronic
insomnia
21 34.0 11 29.6
H1 27 49.1 19 47.4
H2 25 45.6 15 37.1
H1¼ ‘In the past year, have there been times when you heard or saw things that
other people couldn't’. H2¼ ‘Did you at any time hear voices saying quite a few
words or sentences when there was no one around that might account for it?’
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Within the 2000 cross-sectional dataset 3852 were male
(weighted¼46.8%) 4728 were females (weighted¼53.2%). The age
ranged from 16 to 74, the mean weighted age was 43.87 (standard
error¼0.23). In the 2007 cross-sectional dataset 3197 were male
(weighted 48.6%) and 4206 were female (weighted 51.4%). The age
ranged from 16 to 95, mean weighted age was 46.35 (standard
error¼ .03). In the longitudinal dataset 1020 survey respondents
were male (weighted 49.3%) and 1386 were female (weighted
50.7%). The age ranged from 16 to 74, mean weighted age was
43.44 (standard error¼ .49).
The prevalence of insomnia and hallucinatory experiences (H1
and H2) across both the 2000 and 2007 datasets is reported in
Table 1. Probable psychosis was present in 60 cases in the 2000
survey (weighted 0.5%) and 40 cases (weighted 0.4%). Table 2 re-
ports the endorsement of sleep disruption and hallucination
variables in those with probable psychosis.
3.1. The cross-sectional association between insomnia and halluci-
natory experiences
Table 3 presents the associations between insomnia and hal-
lucinatory experiences, from both the 2000 and 2007 datasets.
Experiencing sleep difﬁculties over the past month (I1) increased
the weighted prevalence of hallucinatory experiences (H1) from
2.9–6.6% (2000 dataset) to 3.1–6.3% (2007 dataset). The experience
of chronic insomnia (I3) increased the prevalence of hallucinatory
experiences (H1) from 3.8% to 11.5% (2000) and from 3.8% to 10.8%
(2007). Similarly, sleep difﬁculties increased the weighted pre-
valence of hearing voices saying several words or sentences (H2)
from 0.5% to 1.5% (2000) and from 0.3% to 1.8% (2007). Chronic
insomnia increased the weighted prevalence of endorsing H2 from
0.7% to 3.1% (2000) and from 0.7% to 3.3% (2007).
Associations between each of the three levels of insomnia and
each of the two levels of hallucinatory experience were signiﬁcant
prior to adjustments. In general, the odds ratios (ORs) increased
pari passu as severity of both insomnia and hallucinatory experi-
ences increased. For example, sleep difﬁculties in the month prior
to assessment were associated with a signiﬁcant increase of odds
for seeing or hearing things that others couldn't (H1; 2000
OR¼2.36, 2007 OR¼2.12). Chronic insomnia was associated with a
signiﬁcant increase of odds for hearing voices saying quite a few
words or sentences (H2; 2000 OR¼4.41, 2007 OR¼4.83). As ex-
pected, adjusting for depression, anxiety and paranoia decreased
the size of all ORs. Nevertheless, all but one association remained
signiﬁcant at alpha level .05, following these adjustments. The
exception was chronic insomnia (I3) and hearing voices sayingTable 1
The frequency and weighted prevalence of sleep disruption and hallucinations in
the total 2000 and 2007 datasets.
2000 2007
Frequency Weighted pre-
valence (%)
Frequency Weighted pre-
valence (%)
Sleep
difﬁculties
3380 38.0 3096 39.4
Insomnia 1120 11.9 1123 13.7
Chronic
insomnia
623 6.6 638 7.6
H1 371 4.3 323 4.3
H2 82 0.9 68 0.9
H1¼ ‘In the past year, have there been times when you heard or saw things that
other people couldn't’. H2¼ ‘Did you at any time hear voices saying quite a few
words or sentences when there was no one around that might account for it?’quite a few words or sentences (H2), which became non-sig-
niﬁcant (p¼ .25).
3.2. The longitudinal association between insomnia and the onset of
new hallucinatory experiences
This analysis excluded those who endorsed hallucinatory ex-
periences at time one, in order to assess insomnia as a risk factor
for new hallucinatory experiences. The ORs for the dimensional
measure of insomnia and its association with the two levels of
hallucinatory experiences (H1 and H2) are presented in Table 4.
Insomnia at time one is signiﬁcantly associated with new hallu-
cinatory experiences eighteen months later. Results remained
signiﬁcant after adjustment for baseline levels of anxiety, de-
pression, and paranoia. The odds ratios in Table 4 reﬂect a one-
point increase on the insomnia dimensional scale. A ten-point
increase on the insomnia scale is thus associated with an odds
ratio of 17.3 for hearing voices saying several words (1.33 raised to
the power of 10).4. Discussion
This study used two large nationally representative datasets to
study, for the ﬁrst time, the cross-sectional and longitudinal as-
sociations between insomnia and hallucinatory experiences. In
line with our hypotheses, insomnia was associated with halluci-
natory experiences in both the 2000 and 2007 cross-sectional
datasets. Importantly, this association was not wholly attributable
either to negative affect (depression and anxiety) or to co-morbid
paranoia. As would be expected, controlling for both negative af-
fect and paranoia reduced the size of the associations, but the
direct relationship remained signiﬁcant. The advantage of study-
ing two datasets is that we have built-in replication. The second
key ﬁnding was that initial insomnia was associated with in-
creased inceptions of hallucinatory experiences eighteen months
later. It was only possible to study this effect in one of the surveys.
However the importance of this result lies in its indication that
insomnia is not simply a consequence of hallucinations. Whilst it is
of course possible that insomnia results from hallucinations, the
current results reveals that insomnia may be a risk factor for the
occurrence of hallucinations.
These results add weight to the view that insomnia might have
a contributory causal role in the onset of psychotic experiences
(Freeman et al., 2012). A next step in testing this hypothesis is to
treat insomnia and assess the impact on psychotic experiences (an
approach termed an interventionist model of causality (Kendler
and Campbell, 2009)). A very large (over 2000 participants)
Table 3
The cross-sectional relationship between insomnia and hallucinatory experiences in the 2000 and 2007 datasets.
Unadjusted Adjusting for depression and anxiety Adjusting for depression, anxiety and paranoia
Odds ratio P-value 95% C. I. Odds Ratio P-value 95% C. I. Odds ratio P-value 95% C. I.
2000 dataset
H1: ‘In the past year, have there been times when you heard or saw things that other people couldn't’
I1: Sleep difﬁculties 2.36 o0.001 1.84–3.03 1.76 o0.001
1.35–2.29
1.65 o0.001 1.27–2.16
I2: Insomnia 2.69 o0.001 2.04–3.55 1.71 0.001
1.25–2.34
1.61 0.003 1.17–2.20
I3: Chronic insomnia 3.28 o0.001 2.40–4.50 1.93 o0.001
1.35–2.78
1.86 0.001 1.30–2.66
H2: ‘Did you at any time hear voices saying quite a few words or sentences when there was no one around that might account for it?’
I1: Sleep difﬁculties 3.32 o0.001 2.00–5.52 1.97 0.016
1.13–3.42
1.78 0.044 1.02–3.11
I2: Insomnia 4.14 o0.001 2.56–6.68 1.98 0.017
1.13–3.47
1.82 0.040 1.03–3.21
I3: Chronic insomnia 4.41 o0.001 2.67–7.29 1.83 0.033
1.05–3.18
1.74 0.047 1.01–3.00
2007 dataset
H1: ‘In the past year, have there been times when you heard or saw things that other people couldn't’
I1: Sleep difﬁculties 2.12 o0.001 1.65–2.72 1.66 o0.001 1.27–2.18 1.49 0.005 1.13–1.96
I2: Insomnia 2.56 o0.001 1.92–3.42 1.78 0.001 1.28–2.48 1.61 0.006 1.15–2.25
I3: Chronic insomnia 3.07 o0.001 2.18–4.34 2.03 0.001 1.36–3.01 1.72 0.011 1.13–2.61
H2: ‘Did you at any time hear voices saying quite a few words or sentences when there was no one around that might account for it?’
I1: Sleep difﬁculties 5.22 o0.001 2.74–9.96 3.05 0.003
1.47–6.32
2.69 0.010 1.27–5.66
I2: Insomnia 7.08 o0.001 4.12–12.16 3.56 o0.001
1.76–7.17
3.13 0.002 1.54–6.36
I3: Chronic insomnia 4.83 o0.001 2.65–8.81 1.94 0.071
0.95–3.96
1.55 0.245 0.74–3.27
Table 4
The longitudinal associations between insomnia at time 1 and experience of hal-
lucinatory experiences 18 months later.
Predictor variable n OR P-value 95% CI
H1: ‘In the past year, have there been times when you heard or saw things that
other people couldn't’
Insomnia T1 (dimensional score) 2251 1.17 0.004 1.05–1.30
Insomnia controlling for T1 de-
pression and anxiety
2251 1.14 0.010 1.03–1.26
Insomnia controlling for T1 de-
pression, anxiety and paranoia
2251 1.13 0.013 1.03–1.25
H2: ‘Did you at any time hear voices saying quite a few words or sentences
when there was no one around that might account for it?’
Insomnia T1 (dimensional score) 2375 1.33 0.003 1.10–1.60
Insomnia controlling for T1 de-
pression and anxiety
2375 1.28 0.014 1.05–1.57
Insomnia controlling for T1 de-
pression, anxiety and paranoia
2375 1.28 0.027 1.03–1.58
NB: The odds ratios in this table reﬂect a one-point increase on the insomnia di-
mensional scale. A ten-point increase on the insomnia scale is thus associated with
an odds ratio of 17.3 for hearing voices saying several words (1.33 raised to the
power of 10).
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recommended treatment for persistent insomnia; Morin and
Benca, 2012; National Institute for Health and Care Excellence,
2015) is currently underway (Freeman et al., 2015b). This study
will examine the impact of improved sleep on psychotic like ex-
periences (and other mental health difﬁculties) at an age when
they typically emerge. The intervention will be offered digitally
(via computer and smartphone) which is a cost-effective approach.
Given that the persistence of psychotic experiences (Dominguez
et al., 2009), and the presence of sleep disturbance (Ruhrmannet al., 2010) constitute risk factors for clinical psychosis, the impact
of treating sleep on these sub-clinical phenomena is of both clin-
ical and theoretical interest.
There are clear limitations to the current study. While epide-
miological studies enable the testing of large numbers of people,
they limit the depth of the assessments. The number of people
endorsing hallucinations was small in each dataset. Thus, the
power to study new inceptions of hallucinations was particularly
limited and we could not test whether the few people who had
hallucinations at baseline went on to develop insomnia (i.e. to test
the reverse hypothesis). Our view is that there is likely to be a
reciprocal relationship between insomnia and psychotic experi-
ences such as hallucinations. This bidirectional causal relationship
requires testing in adequately powered studies. Moreover, epide-
miological studies leave open the possibility that confounding and
other related but distinct variables (e.g. past or family history of
sleep and psychiatric disorders) may provide better explanations
for the reported associations between insomnia and hallucina-
tions. While we controlled for two variables where there were a
priori reasons for doing so (negative affect and paranoia), experi-
mental manipulations are needed to rule out whether other fac-
tors, (e.g. substance use) inﬂuence the relationship. Finally, while
it is tempting to assume that inferences from the general popu-
lation apply to clinically relevant ﬁrst episodes of psychosis, it will
be important to conﬁrm this in appropriately designed studies of
high risk individuals.
Notwithstanding these caveats, the current study establishes a
consistent cross sectional association between insomnia and hal-
lucinations, and indicates that insomnia might be one risk factor
for inceptions of hallucinations. These associations mirror those
found between insomnia and paranoia. The clinical implication is
that treating sleep disturbance might alleviate a risk factor
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